Delivery Order SPE2DB25D3109-SPE2DB25FP4PB
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $29,822.56 and is structured under a firm fixed-price arrangement, with an ultimate completion date of October 20, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) on September 26, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded without any set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be performed from the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Erleada 60 mg tablets in a quantity of 120 units. This firm fixed-price delivery order, valued at $7,558.78, is scheduled for completion by September 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating it was awarded through open competition. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 per unit, with a ceiling value of $30,235.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed-price contract, with an ultimate completion date of October 20, 2025, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was competitively made with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Erleada 60 mg tablets in a quantity of 120 units, with a ceiling value of $7,558.78. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires completion by September 17, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,558.78 for 120 tablets of Erleada 60 mg on September 3, 2025, with completion expected by September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $14.7K delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Erleada 240 mg tablets (quantity: 30 units). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 1, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,352.49 for Erleada 240 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price contract award carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary...